Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma.
about
The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary DiseasesMonitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma.Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.Review of the treatment of non-small cell lung cancer with gefitinib.High prevalence of gene abnormalities in young patients with lung cancer.Sex as an independent prognostic factor in a population-based non-small cell lung cancer cohort.Predictive and prognostic value of preoperative serum tumor markers is EGFR mutation-specific in resectable non-small-cell lung cancer.Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status.Factors associated with efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma.
P2860
Q35608617-19077128-D4BF-4D96-8EDB-9E1D4E4D3318Q35854276-A7EEAC62-A96C-43BC-862D-32E67E164E5FQ36095128-6A513C9A-E6F5-4508-B5DF-D2A1C48115D6Q36461805-C2709FF2-36C8-44D7-88C6-E9AC8CE707C5Q36542242-E05AAB70-CED1-4A28-9525-9EE7551BC0CCQ36772978-67287D1A-2E12-42FF-AF59-B57F5EAD638AQ37295811-BB950831-E955-4D1F-8FE8-18D04454DB1CQ37567804-CB22E301-836A-43F5-8945-BBE0C133062EQ39281214-343EC2D9-061A-4277-A1F7-CEC50001C45FQ42288433-0F239AC6-BB2C-405C-A136-86767AD62092
P2860
Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Epidermal growth factor recept ...... ents with lung adenocarcinoma.
@en
Epidermal growth factor recept ...... ents with lung adenocarcinoma.
@nl
type
label
Epidermal growth factor recept ...... ents with lung adenocarcinoma.
@en
Epidermal growth factor recept ...... ents with lung adenocarcinoma.
@nl
prefLabel
Epidermal growth factor recept ...... ents with lung adenocarcinoma.
@en
Epidermal growth factor recept ...... ents with lung adenocarcinoma.
@nl
P2093
P2860
P50
P1433
P1476
Epidermal growth factor recept ...... ents with lung adenocarcinoma.
@en
P2093
Hiroki Otani
Hiroshi Date
Katsuyuki Hotta
Keisuke Aoe
Shinichi Toyooka
Shuji Ichihara
Takayuki Kosaka
Toshimi Takano
Yoshiro Fujiwara
Yuichiro Ohe
P2860
P304
P356
10.1111/J.1349-7006.2007.00688.X
P577
2008-02-01T00:00:00Z